Vaccination coverage against COVID-19 in students and teachers at a dental school in 2022
Article Sidebar
Main Article Content
Abstract
Introduction: the COVID-19 pandemic presented challenges worldwide. The acceptance of vaccines in the population is essential as a preventive measure. It is undeniable that there are factors that increase rejection or questioning in this regard, which may be related to culture, politics, trust, convenience, experience in health services, and also the opinion of the environment.
Objective: to determine the percentage of students and teachers vaccinated, and the number of doses applied against COVID-19 in Facultad de Odontología at the Universidad Nacional de Asunción, in the year 2022.
Methodology: cross-sectional descriptive observational study, applying a digital survey with 23 questions about knowledge, application and self-perception of the vaccine; in addition to demographic data.
Results: 168 respondents were included, 128 students and 40 teachers. 80.0 % were women. 97.6 % have been vaccinated against COVID-19, the majority (85.4 %) received three doses of the vaccine. 34.1 % received the Covaxin vaccine, 32.9 % Sputnik V, 15.9 % AstraZeneca and 17.1 % others (Pfizer, Sinopharm and Moderna). 35.1 % had doubts about the effectiveness but most of them were applied anyway. 94.1 % considered the vaccine necessary and 88.7 % safe. 78.5 % responded that coverage is high to prevent the symptoms of the disease. 35.1% mentioned feeling fully protected with the vaccine. 78.6% know that some adverse reaction may occur after application.
Conclusion: almost all of the respondents were vaccinated and had received all three doses of the COVID-19 vaccine at the time of the survey.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Paraguay. Ministerio de Salud Pública y Bienestar Social. Programa Ampliado de Inmunizaciones. Resumen semanal, plan vacunación: lineamientos técnicos y operativos. Vacunación contra COVID-19 [Internet]. 2021 [citado 9 de junio de 2023]. Asunción: MSPBS-PAI. Disponible en: https://www.vacunate.gov.py/public/xdocumentos/LineamientotcnicyoperativodeVacunacincontraelCOVID-19.pdf
MacDonald NE, Comeau J, Dubé È, Graham J, Greenwood M, Harmon S, et al. Royal society of Canada COVID-19 report: enhancing COVID-19 vaccine acceptance in Canada. FACETS. 2021;6:1184-246.
Kricorian K, Turner K. COVID-19 Vaccine acceptance and beliefs among black and hispanic americans. PLoS One. 2021;16(8):e0256122. doi: 10.1371/journal.pone.0256122
Mahmud S, Mohsin Md, Khan IA, Mian AU, Zaman MA. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLoS One. 2021;16(9):e0257096. doi: 10.1371/journal.pone.0257096.
Sharma M, Davis RE, Wilkerson AH. COVID-19 vaccine acceptance among college students: a theory-based analysis. Int J Environ Res Public Health. 2021;18(9):4617. doi: 10.3390/ijerph18094617.
Mengistu DA, Demmu YM, Asefa YA. Global COVID-19 vaccine acceptance rate: systematic review and meta-analysis. Front Public Health. 2022;10:1044193.
Piltch-Loeb R, Savoia E, Goldberg B, Hughes B, Verhey T, Kayyem J, et al. Examining the effect of information channel on COVID-19 vaccine acceptance. PLoS One. 2021;16(5):e0251095. doi:10.1371/journal.pone.0251095.
Lee C, Holroyd TA, Gur-Arie R, Sauer M, Zavala E, Paul AM, et al. COVID-19 vaccine acceptance among Bangladeshi adults: Understanding predictors of vaccine intention to inform vaccine policy. PLOS ONE. 2022;17(1):e0261929. doi: 10.1371/journal.pone.0261929
Henry DA, Jones MA, Stehlik P, Glasziou PP. Effectiveness of COVID‐19 vaccines: findings from real world studies. Med J Aust. 2021;215(4):149. doi: 10.5694/mja2.51182
Qaderi K, Golezar MH, Mardani A, Mallah MA, Moradi B, Kavoussi H, et al. Cutaneous adverse reactions of COVID ‐19 vaccines: a systematic review. Dermatol Ther [Internet]. 2022 [citado 19 de julio de 2024];35(5):1-7. doi: 10.1111/dth.15391
Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet. Junio de 2020;395(10240):1845-54. Disponible en: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931208-3
Cai C, Peng Y, Shen E, Huang Q, Chen Y, Liu P, et al. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Mol Ther. 2021;29(9):2794-805. doi: 10.1016/j.ymthe.2021.08.001
Wu Q, Dudley MZ, Chen X, Bai X, Dong K, Zhuang T, et al. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med. 2021;19(1):173. doi: 10.1186/s12916-021-02059-5.
Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, et al. The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clin Infect Dis. 2021;73(12):2257-64. doi:10.1093/cid/ciab079
Moreira ED, Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, et al. Safety and efficacy of a third dose of BNT162b2m COVID-19 vaccine. N Engl J Med. 2022;386(20):1910-21. doi: 10.1056/NEJMoa2200674
Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front Immunol. 2021;12:714170. doi:10.3389/fimmu.2021.714170
Farook FF, Mohamed Nuzaim MN, Taha Ababneh K, Alshammari A, Alkadi L. COVID-19mpandemic: oral health challenges and recommendations. Eur J Dent. 2020;14(S 01):S165-70. doi: 10.1055/s-0040-1718641
Jamal M, Shah M, Almarzooqi SH, Aber H, Khawaja S, El Abed R, et al. Overview of transnational recommendations for COVID‐19 transmission control in dental care settings. Oral Dis. 2021;27(S3):655-64. doi: 10.1111/odi.13431.
Quezada Palacios RV. Nivel de aceptación de la vacuna COVID-19 de los estudiantes de estomatología de la Universidad Privada Antenor Orrego. Trujillo – 2021 [Internet] [Tesis para optar por el título profesional de Cirujano Dentista]. Trujillo-Perú: Universidad Privada Antenor Orrego;2021 [citado 9 de junio de 2023]. Disponible en: http://repositorio.upao.edu.pe/bitstream/20.500.12759/8609/1/REP_RAQUEL.QUEZADA_NIVELDE.ACEPTACION.DE.LA.VACUNA.pdf
Onwan M, Matsee W, Lawpoolsri S, Pisutsan P, Siripoon T, Punrin S, et al. Temporal trend of COVID-19 vaccine acceptance and factors influencing international travellers. Trop Med Infect Dis. 2022;7(9):223. doi:10.3390/tropicalmed7090223
Koh SWC, Liow Y, Loh VWK, Liew SJ, Chan YH, Young D. COVID-19 vaccine acceptance and hesitancy among primary healthcare workers in Singapore. BMC Prim Care. 2022;23(1):81. doi: 10.1186/s12875-022-01693-z
Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. E Clinical Medicine. 2020;26:100495. doi: 10.1016/j.eclinm.2020.100495.
Okai GA, Abekah-Nkrumah G. The level and determinants of COVID-19 vaccine acceptance in Ghana. Mossong J, editor. PLOS ONE. 2022;17(7):e0270768. doi: 10.1371/journal.pone.0270768.
Syed Alwi SAR, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021;21(1):1129. doi: 10.1186/s12889-021-11071-6.
Wong LP, Alias H, Danaee M, Ahmed J, Lachyan A, Cai CZ, et al. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries. Infect Dis Poverty. 2021;10(1):122. doi: 10.1186/s40249-021-00900-w.
Eisnecker PS, Kroh M, Kühne S. The role of generalized trust in COVID-19 vaccine acceptance. PLoS One. 2022;17(12):e0278854. doi: 10.1371/journal.pone.0278854.
Reifferscheid L, Lee JSW, MacDonald NE, Sadarangani M, Assi A, Lemaire-Paquette S, et al. Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey. BMC Public Health. 2022;22(1):1745. doi: 10.1186/s12889-022-14025-8.
De Boer J, Saade U, Granjon E, Trouillet-Assant S, Saade C, Pottel H, et al. A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects. Nasrallah GK, editor. PLoS One. 2022;17(9):e0274553. doi:
1371/journal.pone.0274553
Sakamoto M, Ishizuka R, Ozawa C, Fukuda Y. Health information and COVID-19 vaccination: Beliefs and attitudes among Japanese university students. PLoS One. 2022;17(11):e0277435. doi: 10.1371/journal.pone.0270768
Tlale LB, Gabaitiri L, Totolo LK, Smith G, Puswane-Katse O, Ramonna E, et al. Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana. PLoS One. 2022;17(2):e0263375. doi: 10.1371/journal.pone.0277435
Abu Farha RK, Alzoubi KH, Khabour OF, Alfaqih MA. Exploring perception and hesitancy toward COVID-19 vaccine: a study from Jordan. Hum Vaccines Immunother. 2021;17(8):2415-20. doi: 10.1080/21645515.2021.1888633
Lin C, Tu P, Beitsch LM. Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Vaccines. 2020;9(1):16. doi: 10.3390/vaccines9010016
Diario Última Hora. Influenza y COVID-19: salud refuta mitos sobre vacunas y lleva 368.000 dosis aplicadas en 2024. 2 de agosto de 2024 [citado 2 de agosto de 2024]. Disponible en: https://www.ultimahora.com/influenza-y-covid-19-salud-refuta-mitos-sobre-vacunas-y-lleva-368-000-dosis-aplicadas-en-2024
Brannen DE, Howell M, Zindani F, Halderman A. False beliefs and attitude are barriers to COVID-19 vaccination. Disaster Med Public Health Prep. 2023;17:e398. doi: 10.1017/dmp.2023.23
Roswag M, Häusser JA, Abdel Hadi S, Hubert P, Mojzisch A. Organizations affect their employees’ vaccine readiness: A self‐perception theory perspective. Appl Psychol Health WellBeing. 2023;15(4):1603-18. doi: 10.1111/aphw.12457